When our bodies become infected, various immune responses are triggered, starting with a release of granulocytes, white blood cells containing special enzymes that make up about half or more of all human white blood cells.
Mar 9, 2023
0
88
An article recently published in The Journal of Clinical Investigation by the group of Dr. Maria Caffarel and Miguel Servet shows for the first time that the proinflammatory cytokine Oncostatin M (OSM) favors breast cancer ...
Mar 24, 2022
0
5
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...
Dec 18, 2018
0
16
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and ...
Jun 6, 2017
0
129
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors—and the findings could help prevent breast cancer from spreading and enhance the effectiveness ...
Jun 5, 2023
0
40
A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system's "natural killer" cells, shows a study by researchers at the University of California San ...
Jun 22, 2022
0
132
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...
Dec 12, 2017
0
120
A study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) has found that CD4+ T cells, traditionally called 'helper T cells' for their role in aiding the activation of other immune cells, are ...
Jan 19, 2024
0
49
Since the discovery that microRNAs play key roles in regulating human disease, the hope has been that these short non-coding RNA molecules could be translated into a therapeutic strategy for the treatment of cancer. But this ...
Nov 17, 2014
0
0
Kaposi's sarcoma herpesvirus (KSHV) is an etiological agent for Kaposi's sarcoma and two other rare lymphoproliferative malignancies, and it is the most common cancer in HIV-infected untreated individuals. Researchers at ...
Dec 14, 2011
0
0
